0001683168-19-001344.txt : 20190502 0001683168-19-001344.hdr.sgml : 20190502 20190502173148 ACCESSION NUMBER: 0001683168-19-001344 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190422 FILED AS OF DATE: 20190502 DATE AS OF CHANGE: 20190502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Park Chulho CENTRAL INDEX KEY: 0001775662 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 19793282 MAIL ADDRESS: STREET 1: 701 GATEWAY BOULEVARD, SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MATEON THERAPEUTICS INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. STREET 2: SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. STREET 2: SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: OXIGENE INC DATE OF NAME CHANGE: 19930628 3 1 ownership.xml X0206 3 2019-04-22 0 0000908259 MATEON THERAPEUTICS INC MATN 0001775662 Park Chulho 29397 AGOURA ROAD, SUITE 107 AGOURA HILLS CA 91301 0 1 1 0 Chief Technical Officer Common Stock 2811819 D Series A Convertible Preferred Stock 2019-04-22 Common Stock 13285013 D Reflects securities of the Issuer acquired by the reporting person pursuant to the Agreement and Plan of Merger, dated April 22, 2019, by and among the Issuer and Oncotelic, Inc. The Series A Convertible Preferred Stock is convertible at the holder's election and has no expiration date. Each share of Series A Convertible Preferred Stock is convertible into one thousand (1,000) shares of Common Stock. /s/ Chulho Park 2019-05-02